m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0238)
| Name |
ABT-263
|
||||
|---|---|---|---|---|---|
| Formula |
C47H55ClF3N5O6S3
|
||||
| InChI |
1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1
|
||||
| InChIKey |
JLYAXFNOILIKPP-KXQOOQHDSA-N
|
||||
| TTD Drug ID | |||||
| DrugBank ID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT00129 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | Interferon-inducible protein 4 (ADAR1) | |
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | |
| Regulated Target | G1/S-specific cyclin-D1 (CCND1) | |
| Crosstalk relationship | m6A → A-to-I | |